» Articles » PMID: 28445401

Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism

Overview
Journal Nutrients
Date 2017 Apr 27
PMID 28445401
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) causes secondary hyperparathyroidism (SHPT). The cardinal features of SHPT are persistence of normocalcemia as CKD progresses and dependence of the parathyroid hormone concentration ([PTH]) on phosphate influx (I). The tradeoff-in-the-nephron hypothesis integrates these features. It states that as the glomerular filtration rate (GFR) falls, the phosphate concentration ([P]) rises in the cortical distal nephron, the calcium concentration ([Ca]) in that segment falls, and [PTH] rises to maintain normal calcium reabsorption per volume of filtrate (TR/GFR). In a clinical study, we set GFR equal to creatinine clearance (C) and I equal to the urinary excretion rate of phosphorus (E). We employed E/C as a surrogate for [P]. We showed that TR/C was high in patients with primary hyperparathyroidism (PHPT) and normal in those with SHPT despite comparably increased [PTH] in each group. In subjects with SHPT, we examined regressions of [PTH] on E/C before and after treatment with sevelamer carbonate or a placebo. All regressions were significant, and ∆[PTH] correlated with ∆E/C in each treatment cohort. We concluded that [P] determines [PTH] in CKD. This inference explains the cardinal features of SHPT, much of the evidence on which other pathogenic theories are based, and many ancillary observations.

Citing Articles

Association of serum calcium levels with diabetic kidney disease in normocalcemic type 2 diabetes patients: a cross-sectional study.

Yu Q, Xu L, Liang C, Deng Y, Wang P, Yang N Sci Rep. 2024; 14(1):21513.

PMID: 39277673 PMC: 11401904. DOI: 10.1038/s41598-024-72747-8.


Chemical evidence for the tradeoff-in-the-nephron hypothesis to explain secondary hyperparathyroidism.

Phelps K, Gemoets D, May P PLoS One. 2022; 17(8):e0272380.

PMID: 35913960 PMC: 9342777. DOI: 10.1371/journal.pone.0272380.


Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study.

Jung J, Ro H, Chang J, Kim A, Lee H, Han S PLoS One. 2020; 15(6):e0235077.

PMID: 32569271 PMC: 7307748. DOI: 10.1371/journal.pone.0235077.

References
1.
Silver J, Naveh-Many T, Mayer H, Schmelzer H, Popovtzer M . Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986; 78(5):1296-301. PMC: 423816. DOI: 10.1172/JCI112714. View

2.
Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H . Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol. 2008; 19(3):615-23. PMC: 2391049. DOI: 10.1681/ASN.2007060673. View

3.
Rodriguez M, Martin-Malo A, Martinez M, Torres A, Felsenfeld A, Llach F . Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol. Kidney Int. 1991; 40(6):1055-62. DOI: 10.1038/ki.1991.314. View

4.
Phelps K, Stote K, Mason D . Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism. Clin Nephrol. 2014; 82(2):83-91. DOI: 10.5414/CN108223. View

5.
Portale A, Booth B, Halloran B, Morris Jr R . Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest. 1984; 73(6):1580-9. PMC: 437069. DOI: 10.1172/JCI111365. View